Compare · ITGR vs VANI
ITGR vs VANI
Side-by-side comparison of Integer Holdings Corporation (ITGR) and Vivani Medical Inc. (VANI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ITGR and VANI operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
- ITGR is the larger of the two at $3.24B, about 28.5x VANI ($113.8M).
- Over the past year, ITGR is down 15.3% and VANI is down 16.8% - ITGR leads by 1.5 points.
- VANI has been more active in the news (19 items in the past 4 weeks vs 6 for ITGR).
- ITGR has more recent analyst coverage (23 ratings vs 0 for VANI).
- Company
- Integer Holdings Corporation
- Vivani Medical Inc.
- Price
- -
- -
- Market cap
- $3.24B
- $113.8M
- 1M return
- +4.58%
- +9.17%
- 1Y return
- -15.28%
- -16.83%
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NYSE
- NASDAQ
- IPO
- 2014
- News (4w)
- 6
- 19
- Recent ratings
- 23
- 0
Integer Holdings Corporation
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates in two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and management systems, charging and docking stations, and power supplies for the energy, military, and environmental markets. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.
Latest ITGR
- SEC Form 3 filed by new insider Metcalf Milo Stephen Ii
- SEC Form 4 filed by US - EVP, Operations Metcalf Milo Stephen Ii
- Integer Announces Conference Call to Discuss Second Quarter 2026 Results
- Chief Human Resources Officer Thor Kirk K converted options into 6,120 shares and covered exercise/tax liability with 2,409 shares, increasing direct ownership by 11% to 38,693 units (SEC Form 4)
- SEC Form 4 filed by President, Glob Ops & Manu Tec Harris John A
- Integer Holdings Corporation filed SEC Form 8-K: Leadership Update
- Integer to Participate in Truist Securities 2026 MedTech Conference on June 16
- Director Maxwell Martin C was granted 1,967 shares, increasing direct ownership by 9% to 25,106 units (SEC Form 4)
- SEC Form 4 filed by Director Hinrichs James F.
- Director Coyle Michael J was granted 1,967 shares, increasing direct ownership by 145% to 3,322 units (SEC Form 4)
Latest VANI
- Director Williams Gregg bought $999,999 worth of shares (793,650 units at $1.26) (SEC Form 4)
- Vivani Medical Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Presenting on Emerging Growth Conference 94 Day 2 on July 16; Register to live stream
- Vivani Medical to Present at the Emerging Growth Conference on July 15, 2026
- Presenting on Emerging Growth Conference 94 Day 1 on July 15; Register to live stream
- Vivani Medical Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
- Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management
- ClearOne Announces Entry into Merger Agreement with Cortigent, Inc., a Wholly-Owned Subsidiary of Vivani Medical
- Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.
- Vivani Medical Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits